To assess whether cytotoxicity of the IgG1-Campath-RGE and IgG1-11B8-AGK antibody combination is restricted to cells co-expressing CD52 and CD20, we analyzed the CDC activity of individual and mixed antibody components on six tumor B cell lines with variable CD52 and CD20 expression levels. The gene discussed is CD52; the disease is neoplasm.